Abbott Laboratories (ABT)


NYSE - NYSE Real Time Price. Currency in USD
42.98+0.14 (+0.33%)
At close: 4:00 PM EDT
People also watch:
ABBVBMYLLYJNJMRK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open42.72
Prev Close42.84
Bid42.96 x 100
Ask43.08 x 100
Day's Range42.09 - 43.28
52wk Range36.00 - 46.63
1y Target EstN/A
Market Cap63.18B
P/E Ratio (ttm)28.37
Beta1.57
Volume18,306,073
Avg Vol (3m)10,372,698
Dividend & Yield1.04 (2.42%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Benzinga7 hours ago

    Here Are All The Big Biotech Mergers In 2016

    Biotech is one of the sectors where M&A activities never stop, as the potential for growth and development is immense. After the termination of a $160 billion merger with Allergan plc Ordinary Shares (NYSE: ...

  • Reuters13 hours ago

    Whiplashed investors stay skittish about St. Jude

    One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it. St. Jude's stock at one point fell around 3 percent on Friday, though it ended the day slightly up, following a drop of around 5 percent on Thursday after Muddy Waters Capital leveled the accusation against St. Jude. St. Jude in April agreed to sell itself to Abbott, and the deal was widely considered a slam dunk before the cyber security concerns were raised.

  • Alere shares fall after it sued Abbott over $5.8 billion deal
    CNBCyesterday

    Alere shares fall after it sued Abbott over $5.8 billion deal

    Alere fell 3 percent after it sued Abbott to compel it to get all antitrust approvals required to complete its $5.8 billion merger.